Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.01 | uM | 9 | 156.25 | 71.09 | 79.00 | 118.00 | 0.6695 | 0.1552 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 156.25 | 71.09 | 68.00 | 118.00 | 0.5763 | -0.0590 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 156.25 | 71.09 | 171.00 | 118.00 | 1.4492 | 2.3221 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 130.00 | 118.00 | 1.1017 | 1.2833 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 71.09 | 66.00 | 118.00 | 0.5593 | -0.0966 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 156.25 | 71.09 | 138.00 | 118.00 | 1.1695 | 1.4777 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 172.00 | 118.00 | 1.4576 | 2.3487 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 426.00 | 118.00 | 3.6102 | 10.5790 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 130.00 | 118.00 | 1.1017 | 1.2833 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 71.09 | 103.00 | 118.00 | 0.8729 | 0.6606 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 156.25 | 71.09 | 32.00 | 118.00 | 0.2712 | -0.6644 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 98.00 | 118.00 | 0.8305 | 0.5513 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 363.00 | 328.00 | 1.1067 | 1.1943 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 312.50 | 153.73 | 289.00 | 328.00 | 0.8811 | 0.7813 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 312.50 | 153.73 | 264.00 | 328.00 | 0.8049 | 0.6399 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 390.00 | 328.00 | 1.1890 | 1.3432 |
| BT-20 | Erlotinib | 1 | uM | 9 | 312.50 | 153.73 | 383.00 | 328.00 | 1.1677 | 1.3047 |
| BT-20 | Lapatinib | 10 | uM | 9 | 312.50 | 153.73 | 158.00 | 328.00 | 0.4817 | 0.0254 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 450.00 | 328.00 | 1.3720 | 1.6708 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 312.50 | 153.73 | 472.00 | 328.00 | 1.4390 | 1.7900 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 513.00 | 328.00 | 1.5640 | 2.0109 |
| BT-20 | Lapatinib | 1 | uM | 9 | 312.50 | 153.73 | 464.00 | 328.00 | 1.4146 | 1.7467 |
| BT-20 | Linsitinib | 10 | uM | 9 | 312.50 | 153.73 | 273.00 | 328.00 | 0.8323 | 0.6909 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 298.00 | 328.00 | 0.9085 | 0.8320 |
| BT-20 | Erlotinib | 10 | uM | 9 | 312.50 | 153.73 | 329.00 | 328.00 | 1.0030 | 1.0056 |